Auxilium’s Peyronie’s Strategy: Start With Few Urologists, Broad Patient Population
This article was originally published in The Pink Sheet Daily
Xiaflex is first drug approved for Peyronie’s disease; initial marketing will focus on physicians that already provide invasive treatment.
You may also be interested in...
The Irish company made its interest for Auxilium public, but the takeover target is not ready to break its previous merger agreement with Canadian drugmaker QLT.
Auxilium’s Xiaflex sales still languish, but its older testosterone product continues to drive growth for the company.
REMS does not restrict type of physician who can administer the collagenase enzyme, which will launch in March.